Prostate Cancer Incidence Trends Increasing
WEDNESDAY, Sept. 3, 2025 -- Prostate cancer incidence is increasing, according to a report published online Sept. 2 in CA: A Cancer Journal for Clinicians.
Tyler B. Kratzer, M.P.H., from the American Cancer Society in Atlanta, and colleagues used population‐based incidence and mortality data to provide an overview of prostate cancer occurrence.
The authors observed a reversal in prostate cancer incidence trends from a decline of 6.4 percent per year during 2007 to 2014 to an increase of 3.0 percent per year during 2014 through 2021. The increasing trend was seen in distant-stage disease in men younger than 55 years, regional/distant-stage disease in men aged 55 to 69 years, and early-stage disease in men aged 70 years and older. Distant-stage disease increased by 2.6, 6.0, and 6.2 percent annually in men aged younger than 55 years, those aged 55 to 69 years, and those aged 70 years and older, respectively, during the past decade. Compared with Black and White men, American Indian/Alaska Native, Asian American/Pacific Islander, and Hispanic men were less likely to be diagnosed with localized disease (64 to 67 versus 71 to 72 percent). Compared with White men, American Indian/Alaska Native men had a 13 percent lower incidence but 12 percent higher prostate cancer mortality, while Black men had a 67 percent higher incidence and double the prostate cancer mortality.
"Our report underscores the need to redouble efforts to optimize early diagnosis that minimizes overdetection and to also ensure those strategies reach Black and Native American communities in particular," senior author Rebecca L. Siegel, M.P.H., from the American Cancer Society, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Higher Tattoo Exposure Linked to Reduced Melanoma Risk
MONDAY, Sept. 29, 2025 -- Higher tattoo exposure may be associated with reduced melanoma risk, according to a study published online Aug. 21 in the Journal of the National Cancer...
Antithymocyte Globulin Cuts Loss of β-Cell Function in Type 1 Diabetes
MONDAY, Sept. 29, 2025 -- Antithymocyte globulin (ATG) 2.5 and 0.5 mg/kg reduces loss of β-cell function in young people with recent-onset type 1 diabetes, according to a...
Loss of Therapeutic Benefit Seen After Stopping Baricitinib in Type 1 Diabetes
MONDAY, Sept. 29, 2025 -- Two-year follow-up shows a loss of therapeutic benefit when baricitinib treatment is stopped in type 1 diabetes (T1D), according to a study presented at...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.